Evaluation of a New Homogeneous Immunoassay for Quantification of Prothrombin Fragment 1+2 (F1+2)
Mattthias Ehm
Siemens Healthineers
|
Prothrombin fragment F1+2 aids in the risk assessment of thrombosis and efficacy of anticoagulant treatment monitoring. Now for the first time, LOCI® technology* is being used to deliver an improved testing method for the measurement of F1+2. Watch a short video and learn how this assay† has the potential to offer:
- The first and only automated determination of F1+2
- Excellent sensitivity and precision
- A dynamic assay measuring range of up to 5000 pmol/L
Compartir esta página:
*Oxygen channeling technology.
†Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.